We are live on ! Find out more

2,338 hedge funds and large institutions have $102B invested in Amgen in 2022 Q1 according to their latest regulatory filings, with 182 funds opening new positions, 983 increasing their positions, 828 reducing their positions, and 108 closing their positions.

New
Increased
Maintained
Reduced
Closed

76% more funds holding in top 10

Funds holding in top 10: 29 → 51 (+22)

69% more first-time investments, than exits

New positions opened: 182 | Existing positions closed: 108

19% more repeat investments, than reductions

Existing positions increased: 983 | Existing positions reduced: 828

2% more funds holding

Funds holding: 2,295 → 2,338 (+43)

0.35% more ownership

Funds ownership: 75.37% → 75.72% (+0.35%)

5% less call options, than puts

Call options by funds: $1.81B | Put options by funds: $1.91B

10% less capital inflows, than outflows

Capital inflows: $5.07B | Capital outflows: $5.63B

Holders
2,338
Holders Change
+43
Holders Change %
+1.87%
% of All Funds
36.73%
Holding in Top 10
51
Holding in Top 10 Change
+22
Holding in Top 10 Change %
+75.86%
% of All Funds
0.8%
New
182
Increased
983
Reduced
828
Closed
108
Calls
$1.81​B
Puts
$1.91​B
Net Calls
-⁠$100​M
Net Calls Change
-⁠$113​M

AMGN Hedge Fund Activity: Q1 2022 in Review

2,338 of the 6,366 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q1 2022, worth a combined $102B — up 6.8% from $95.5B a quarter earlier.

Buyers outnumbered sellers: 182 funds opened new AMGN positions and 108 closed out — a net gain of 74 holders — while 983 added to existing stakes and 828 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $1.1B. The largest seller was Capital Research Global Investors, cutting an estimated $856M.

  • 2,338 institutional investors held Amgen (AMGN) as of Q1 2022, up from 2,295 in Q4 2021.
  • Funds reported $102B of Amgen stock for Q1 2022, up 6.8% quarter-over-quarter.
  • 182 funds opened new Amgen positions in Q1 2022 and 108 closed out, a net change of +74 holders.
  • The largest Amgen buyer in Q1 2022 was Morgan Stanley, an estimated $1.1B added.
  • The largest Amgen seller in Q1 2022 was Capital Research Global Investors, an estimated $856M sold.

Based on aggregated 13F filings for Q1 2022.